Today, we are excited to announce that we have finally secured a long-overdue secondary breast cancer audit in England, delivering on one of the key calls from our Unsurvivors campaign.
A new targeted drug for treating breast cancer that has spread has been approved by the National Institute for Health and Care Excellence (NICE) for use on the Cancer Drugs Fund.
Our 2019 report, which looked at the experiences of over 2,000 people living with secondary breast cancer, found that many were experiencing avoidable delays in diagnosis.
Our Policy team have an update on the ongoing NICE methods and process review, and how we’re helping to ensure the system works for breast cancer drugs.
Drugs are a cornerstone of treatment for breast cancer. We know that you may have questions about drug treatment following the transition period ending on 31 December 2020. We take a look at what this means for medicines supply, medicines licensing, and clinical trials.
Natasha was diagnosed with secondary breast cancer at the age of 43. She tells us about her experience of being diagnosed and living with secondary breast cancer.
Anna, a 53-year-old mother of two, has been living with secondary breast cancer since 2017. Here, she talks about how her life has changed – and how it hasn't.
A year ago, along with some of the incredible women involved in our secondary breast cancer campaign, we went to parliament to deliver a petition with more than 70,000 signatures to the Cancer Minister, Jo Churchill.
Gillian was diagnosed with secondary breast cancer in January 2020. She tells us about the difficulties she faced getting diagnosed and what her life is like now.